When small becomes big: The new challenges of orphan drugs in Europe

Throughout the years the European pharmaceutical landscape has undergone a significant shift, resulting in an increasing acknowledgment of specialty medicines and diseases with lesser patient population.

The orphan drugs landscape has become a commercially attractive market as a result of vigorous patient advocacy, medical breakthroughs, regulatory incentives and venture capital investment.

This year’s 6th annual Orphan Drugs and Rare Diseases Europe conference will deliver an in-depth overview of the regulatory landscape, pricing strategy and orphan drug development over two days.

Bertram Haussler, Chairman of the Board of Management, IGES Institut will be presenting the host nation address, which will be focused on active measures to improve the health situation of those living with rare diseases in Germany.

Some of the topical areas of discussion will include regulatory developments, strategies for best route to market, pricing and reimbursement concerns including the controversial German pricing mechanism. Other conference highlights to expect this year will include:

• SIX spotlight sessions
• Opening keynote from Alexion Pharma
• Host nation address from IGES Institut
• TWO interactive post conference workshops
• Global drug market case studies from Italy, Middle East, Greece & the UK
• Topical panel discussion from Global Market Access Solutions, Agerion Pharmaceuticals, RBV Capital
• FIVE+ hours of networking opportunities with senior industry professionals

Visit www.orphandrugs-event.com/openpr for more information or to view the complete two day agenda.

There is currently a £400 early bird discount for all bookings made before 31st January.

Orphan Drugs and Rare Diseases Europe 2017
15th – 16th May 2017
Berlin, Germany
www.orphandrugs-event.com/openpr
Follow the conversation on Twitter and LinkedIn at #SMiOD17

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

SMi group
1 Westminister Bridge Road
London
SE1 7XW

This release was published on openPR.